Magid D, Fishman E K, Wharam M D, Siegelman S S
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD.
J Comput Assist Tomogr. 1988 Mar-Apr;12(2):222-6. doi: 10.1097/00004728-198803000-00009.
Musculoskeletal desmoid tumors can be difficult to characterize and to follow. The rate of regression after radiotherapy is variable, with poor response to chemotherapy and postoperative recurrence being common. Eighteen patients undergoing therapy for proven musculoskeletal desmoid tumors had 52 CT studies, which were assessed to determine the utility of CT in following such patients. Computed tomography was found to offer excellent initial baselines prior to additional treatment and in the early postoperative period and followed the tumor response to treatment. Ultimate tumor response could not be predicted by characteristics of or change in tumor margins, by initial or subsequent tumor CT attenuation, by appearance following intravenous contrast medium, or by tumor location. Decreasing size and stabilization of size in a previously growing lesion were the only reliable signs of response; markedly increasing attenuation heterogeneity suggested but was unreliable as an isolated sign of response.
肌肉骨骼韧带样瘤可能难以定性和随访。放疗后的消退率不一,对化疗反应不佳且术后复发常见。18例接受已确诊肌肉骨骼韧带样瘤治疗的患者进行了52次CT检查,对这些检查进行评估以确定CT在随访此类患者中的作用。结果发现,计算机断层扫描在额外治疗前和术后早期可提供出色的初始基线,并可跟踪肿瘤对治疗的反应。肿瘤边缘的特征或变化、初始或后续肿瘤CT衰减、静脉注射造影剂后的表现或肿瘤位置均无法预测最终的肿瘤反应。先前生长的病变大小减小和稳定是唯一可靠的反应迹象;明显增加的衰减异质性提示有反应,但作为单独的反应迹象并不可靠。